If a person decides to pursueradical therapy, it means:

1. They have a definite diagnosis of prostate cancer like intermediate-risk prostate cancer.

2. The risk of prostate cancer progression (metastasis and death) is high enough to warrant the potential morbidity/symptoms of treatment (e.g. surgery, radiation therapy, chemoyjerapy)

Radical therapy may have side effects depending on what type is chosen. These symptoms can be managed by additional treatment.

When someone chooses active surveillance, it means:

1. They have a definite diagnosis of prostate cancer – like intermediate-risk prostate cancer.

2. Their cancer is not an immediate threat.

3. They have chosen to be closely monitored with regular tests and immediate treatment if any changes in their condition require it.

The tests used will depend on your treating clinician’s recommendations and your agreement: they may be blood tests, regular scans, and/or tumour sample tests. Active surveillance exists to prevent unnecessary treatment and the potential side effects of said treatment. Genomic testing may help you and your clinician understand your risk and make your best treatment decision.